Von Willebrand factor: another janus-faced hemostasis protein

Area of Science:

• Hematology
• Vascular Biology
• Protein Science

Background:

• Von Willebrand factor (VWF) is a plasma protein essential for hemostasis, mediating platelet adhesion and aggregation.
• VWF also functions as a carrier for coagulation factor VIII.
• While VWF deficiency causes bleeding disorders, elevated levels and specific VWF forms are linked to thrombotic events.

Purpose of the Study:

• To review the literature on the dual role of von Willebrand factor (VWF).
• To provide evidence for VWF's involvement in both bleeding and clotting.
• To highlight VWF's complex role in vascular health and disease.

Main Methods:

• Literature review of studies on von Willebrand factor (VWF).
• Analysis of VWF's role in hemostasis and thrombosis.
• Examination of conditions associated with VWF abnormalities, such as thrombotic thrombocytopenic purpura and atherothrombosis.

Main Results:

• Von Willebrand factor (VWF) deficiency is linked to bleeding tendencies.
• Unusually large VWF multimers, due to ADAMTS13 deficiency, are implicated in thrombotic thrombocytopenic purpura.
• High plasma VWF levels are associated with increased risk of atherothrombosis.

Conclusions:

• Von Willebrand factor (VWF) exhibits a dual role, participating in both bleeding and thrombosis.
• VWF's function is context-dependent, influenced by its multimeric structure and plasma levels.
• Further research into VWF's complex pathophysiology is warranted for therapeutic strategies.